Skip to main content

MoneyWorks4Me

Aurobindo Pharma informs about press release

26 May 2022 Evaluate

Aurobindo Pharma has informed that it enclosed copy of the Press Release that is being issued by the Company in connection with USFDA approval received by Eugia Pharma Specialities, a wholly owned subsidiary of the Company, for Pemetrexed for Injection.

The above information is a part of company’s filings submitted to BSE.



Peers
Company Name CMP
Sun Pharma. Inds. 1797.20
Dr. Reddys Labs. 1352.55
Cipla 1373.70
Lupin 2010.00
Zydus Lifesciences 1238.25
View more..